Which medications in the drug class Antineoplastics, Alkylating are used in the treatment of Liposarcoma?

Updated: Mar 18, 2020
  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Dirk M Elston, MD  more...
  • Print

Antineoplastics, Alkylating

Treatment with trabectedin may be considered in patients who have already received an anthracycline.

Trabectedin (Yondelis)

Trabectedin is an alkylating drug that binds guanine residues in the minor groove of DNA. It is indicated for unresectable or metastatic liposarcoma or leiomyosarcoma in patients who have received a prior anthracycline-containing regimen.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!